
0:00
1:16:31
Millions face debilitating hearing loss, tinnitus, and vertigo, but a medical breakthrough could soon offer true recovery. Trey speaks with ENT expert and CEO of Sound Pharmaceuticals, Dr. Jonathan Kil, to unpack the alarming connection between untreated hearing loss and dementia risk. Dr. Kil shares his personal experience with severe vertigo and details the 25-year journey behind SPI-1005, a landmark oral drug targeting Meniere's disease.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
Fler avsnitt från "The Trey Gowdy Podcast"



Missa inte ett avsnitt av “The Trey Gowdy Podcast” och prenumerera på det i GetPodcast-appen.








